Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development

Progress in Neurobiology

Volumn 130, Issue , 2015, Pages 1-28

  Meechan, Daniel W ^a   Maynard, Thomas M ^a   Tucker, Eric S ^b   Fernandez, Alejandra ^a   Karpinski, Beverly A ^a   Rothblat, Lawrence A ^a,c   LaMantia, Anthony S ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

ADHD; Animal models; Autism; Cortex; Schizophrenia

Indexed keywords

DGCR8 PROTEIN; PRODH PROTEIN; PROTEIN; RANBP1 PROTEIN; TBX1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN; BRAIN DEVELOPMENT; BRAIN DISEASE; CARDIOVASCULAR MALFORMATION; CELL MIGRATION; CELLULAR NEUROPATHOLOGY; CHROMOSOME DELETION 22Q11; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; DISORDERS OF CORTICAL CIRCUIT DEVELOPMENT; DYSPHAGIA; GENETIC DISORDER; GENETIC MODEL; HEART ATRIUM SEPTUM DEFECT; HUMAN; HUMAN CHROMOSOME; INCIDENCE; INTERNEURON; MOUSE; MOUSE MODEL; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; ANIMAL; BRAIN CORTEX; CHROMOSOME 22; DIGEORGE SYNDROME; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

ANIMALS; CEREBRAL CORTEX; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; SCHIZOPHRENIA;

EID: 84930766362     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2015.03.004     Document Type: Review

References (310)

1. Albrecht U., Sutcliffe J.S., Cattanach B.M., Beechey C.V., Armstrong D., Eichele G., Beaudet A.L. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet. 1997, 17:75-78.
2. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
3. Andersson F., Glaser B., Spiridon M., Debbane M., Vuilleumier P., Eliez S. Impaired activation of face processing networks revealed by functional magnetic resonance imaging in 22q11.2 deletion syndrome. Biol. Psychiatry 2008, 63:49-57.
4. Andreassen O.A., Djurovic S., Thompson W.K., Schork A.J., Kendler K.S., O'Donovan M.C., Rujescu D., Werge T., van de Bunt M., Morris A.P., McCarthy M.I., International Consortium for Blood Pressure G., Diabetes Genetics R., Meta-analysis C., Psychiatric Genomics Consortium Schizophrenia Working G., Roddey J.C., McEvoy L.K., Desikan R.S., Dale A.M. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum. Genet. 2013, 92:197-209.
5. Antshel K.M., Aneja A., Strunge L., Peebles J., Fremont W.P., Stallone K., Abdulsabur N., Higgins A.M., Shprintzen R.J., Kates W.R. Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J. Autism Dev. Disord. 2007, 37:1776-1786.
6. Arnold S.J., Huang G.J., Cheung A.F., Era T., Nishikawa S., Bikoff E.K., Molnar Z., Robertson E.J., Groszer M. The T-box transcription factor Eomes/Tbr2 regulates neurogenesis in the cortical subventricular zone. Genes Dev. 2008, 22:2479-2484.
7. Ashtari M., Kumra S., Bhaskar S.L., Clarke T., Thaden E., Cervellione K.L., Rhinewine J., Kane J.M., Adesman A., Milanaik R., Maytal J., Diamond A., Szeszko P., Ardekani B.A. Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol. Psychiatry 2005, 57:448-455.
8. Babcock M., Yatsenko S., Hopkins J., Brenton M., Cao Q., de Jong P., Stankiewicz P., Lupski J.R., Sikela J.M., Morrow B.E. Hominoid lineage specific amplification of low-copy repeats on 22q11.2 (LCR22s) associated with velo-cardio-facial/digeorge syndrome. Hum. Mol. Genet. 2007, 16:2560-2571.
9. Bachiller D., Klingensmith J., Shneyder N., Tran U., Anderson R., Rossant J., De Robertis E.M. The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 2003, 130:3567-3578.
10. Baker J.T., Holmes A.J., Masters G.A., Yeo B.T., Krienen F., Buckner R.L., Ongur D. Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder. JAMA Psychiatry 2014, 71:109-118.
11. Barch D.M., Csernansky J.G. Abnormal parietal cortex activation during working memory in schizophrenia: verbal phonological coding disturbances versus domain-general executive dysfunction. Am. J. Psychiatry 2007, 164:1090-1098.
12. Barnea-Goraly N., Menon V., Krasnow B., Ko A., Reiss A., Eliez S. Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study. Am. J. Psychiatry 2003, 160:1863-1869.
13. Bassett A.S., Chow E.W. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol. Psychiatry 1999, 46:882-891.
14. Bassett A.S., Chow E.W., Husted J., Weksberg R., Caluseriu O., Webb G.D., Gatzoulis M.A. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am. J. Med. Genet. A 2005, 138:307-313.
15. Bearden C.E., van Erp T.G., Dutton R.A., Tran H., Zimmermann L., Sun D., Geaga J.A., Simon T.J., Glahn D.C., Cannon T.D., Emanuel B.S., Toga A.W., Thompson P.M. Mapping cortical thickness in children with 22q11.2 deletions. Cereb. Cortex 2007, 17:1889-1898.
16. Bearden C.E., van Erp T.G., Dutton R.A., Lee A.D., Simon T.J., Cannon T.D., Emanuel B.S., McDonald-McGinn D., Zackai E.H., Thompson P.M. Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions. Cereb. Cortex 2009, 19:115-126.
17. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 1997, 24:349-355.
18. Beasley C.L., Zhang Z.J., Patten I., Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry 2002, 52:708-715.
19. Beckmann J.S., Estivill X., Antonarakis S.E. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat. Rev. Genet. 2007, 8:639-646.
20. Belinsky G.S., Rich M.T., Sirois C.L., Short S.M., Pedrosa E., Lachman H.M., Antic S.D. Patch-clamp recordings and calcium imaging followed by single-cell PCR reveal the developmental profile of 13 genes in iPSC-derived human neurons. Stem Cell Res. 2014, 12:101-118.
21. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 2000, 31:251-269.
22. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 1991, 48:996-1001.
23. Benes F.M., Vincent S.L., Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry 2001, 50:395-406.
24. Beneyto M., Abbott A., Hashimoto T., Lewis D.A. Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb. Cortex 2011, 21:999-1011.
25. Besseau-Ayasse J., Violle-Poirsier C., Bazin A., Gruchy N., Moncla A., Girard F., Till M., Mugneret F., Coussement A., Pelluard F., Jimenez M., Vago P., Portnoi M.F., Dupont C., Beneteau C., Amblard F., Valduga M., Bresson J.L., Carre-Pigeon F., Le Meur N., Tapia S., Yardin C., Receveur A., Lespinasse J., Pipiras E., Beaujard M.P., Teboul P., Brisset S., Catty M., Nowak E., Douet Guilbert N., Lallaoui H., Bouquillon S., Gatinois V., Joly-Helas G., Prieur F., Cartault F., Martin D., Kleinfinger P., Molina Gomes D., Doco-Fenzy M., Vialard F. A French collaborative survey of 272 fetuses with 22q11.2 deletion: ultrasound findings, fetal autopsies and pregnancy outcomes. Prenat. Diagn. 2014, 34:424-430.
26. Bingham P.M., Lynch D., McDonald-McGinn D., Zackai E. Polymicrogyria in chromosome 22 deletion syndrome. Neurology 1998, 51:1500-1502.
27. Bonilha L., Cendes F., Rorden C., Eckert M., Dalgalarrondo P., Li L.M., Steiner C.E. Gray and white matter imbalance - typical structural abnormality underlying classic autism?. Brain Dev. 2008, 30:396-401.
28. Botto L.D., May K., Fernhoff P.M., Correa A., Coleman K., Rasmussen S.A., Merritt R.K., O'Leary L.A., Wong L.Y., Elixson E.M., Mahle W.T., Campbell R.M. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003, 112:101-107.
29. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
30. Braunstein E.M., Monks D.C., Aggarwal V.S., Arnold J.S., Morrow B.E. Tbx1 and Brn4 regulate retinoic acid metabolic genes during cochlear morphogenesis. BMC Dev. Biol. 2009, 9:31.
31. Brennand K., Savas J.N., Kim Y., Tran N., Simone A., Hashimoto-Torii K., Beaumont K.G., Kim H.J., Topol A., Ladran I., Abdelrahim M., Matikainen-Ankney B., Chao S.H., Mrksich M., Rakic P., Fang G., Zhang B., Yates J.R., Gage F.H. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 2015, 20:361-368.
32. Brigman J.L., Rothblat L.A. Stimulus specific deficit on visual reversal learning after lesions of medial prefrontal cortex in the mouse. Behav. Brain Res. 2008, 187:405-410.
33. Brigman J.L., Padukiewicz K.E., Sutherland M.L., Rothblat L.A. Executive functions in the heterozygous reeler mouse model of schizophrenia. Behav. Neurosci. 2006, 120:984-988.
34. Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain's default network: anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 2008, 1124:1-38.
35. Bush G. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol. Psychiatry 2011, 69:1160-1167.
36. Bussey T.J., Muir J.L., Everitt B.J., Robbins T.W. Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behav. Neurosci. 1997, 111:920-936.
37. Cannizzaro L.A., Emanuel B.S. In situ hybridization and translocation breakpoint mapping. III. DiGeorge syndrome with partial monosomy of chromosome 22. Cytogenet. Cell Genet. 1985, 39:179-183.
38. Carlson C., Sirotkin H., Pandita R., Goldberg R., McKie J., Wadey R., Patanjali S.R., Weissman S.M., Anyane-Yeboa K., Warburton D., Scambler P., Shprintzen R., Kucherlapati R., Morrow B.E. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am. J. Hum. Genet. 1997, 61:620-629.
39. Casanova M.F., Buxhoeveden D.P., Switala A.E., Roy E. Minicolumnar pathology in autism. Neurology 2002, 58:428-432.
40. Casanova M.F., Kreczmanski P., Trippe J., Switala A., Heinsen H., Steinbusch H.W., Schmitz C. Neuronal distribution in the neocortex of schizophrenic patients. Psychiatry Res. 2008, 158:267-277.
41. Catalina-Rodriguez O., Kolukula V.K., Tomita Y., Preet A., Palmieri F., Wellstein A., Byers S., Giaccia A.J., Glasgow E., Albanese C., Avantaggiati M.L. The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget 2012, 3:1220-1235.
42. Caviness V.S. Architectonic map of neocortex of the normal mouse. J. Compar. Neurol. 1975, 164:247-263.
43. Chapman R.S., Hesketh L.J. Behavioral phenotype of individuals with Down syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 2000, 6:84-95.
44. Chattopadhyaya B., Cristo G.D. GABAergic circuit dysfunctions in neurodevelopmental disorders. Front. Psychiatry 2012, 3:51.
45. Chen H.Y., Yeh J.I., Hong C.J., Chen C.H. Mutation analysis of ARVCF gene on chromosome 22q11 as a candidate for a schizophrenia gene. Schizophr. Res. 2005, 72:275-277.
46. Chen Y.Z., Matsushita M., Girirajan S., Lisowski M., Sun E., Sul Y., Bernier R., Estes A., Dawson G., Minshew N., Shellenberg G.D., Eichler E.E., Rieder M.J., Nickerson D.A., Tsuang D.W., Tsuang M.T., Wijsman E.M., Raskind W.H., Brkanac Z. Evidence for involvement of GNB1L in autism. Am. J. Med. Genet. B: Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatric Genet. 2012, 159B:61-71.
47. Cheung E.N., George S.R., Costain G.A., Andrade D.M., Chow E.W., Silversides C.K., Bassett A.S. Prevalence of hypocalcaemia and its associated features in 22q11.2 deletion syndrome. Clin. Endocrinol. (Oxf.) 2014, 81:190-196.
48. Choi J.H., Shin Y.L., Kim G.H., Seo E.J., Kim Y., Park I.S., Yoo H.W. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm. Res. 2005, 63:294-299.
49. Chu J., Anderson S.A. Development of cortical interneurons. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2015, 40:16-23.
50. Chudasama Y., Robbins T.W. Dissociable contributions of the orbitofrontal and infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: further evidence for the functional heterogeneity of the rodent frontal cortex. J. Neurosci. 2003, 23:8771-8780.
51. Conrad M., Jakupoglu C., Moreno S.G., Lippl S., Banjac A., Schneider M., Beck H., Hatzopoulos A.K., Just U., Sinowatz F., Schmahl W., Chien K.R., Wurst W., Bornkamm G.W., Brielmeier M. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol. Cell. Biol. 2004, 24:9414-9423.
52. Conturo T.E., Williams D.L., Smith C.D., Gultepe E., Akbudak E., Minshew N.J. Neuronal fiber pathway abnormalities in autism: an initial MRI diffusion tensor tracking study of hippocampo-fusiform and amygdalo-fusiform pathways. J. Int. Neuropsychol. Soc. 2008, 14:933-946.
53. Cordes S.P. Molecular genetics of cranial nerve development in mouse. Nat. Rev. Neurosci. 2001, 2:611-623.
54. Courchesne E., Karns C.M., Davis H.R., Ziccardi R., Carper R.A., Tigue Z.D., Chisum H.J., Moses P., Pierce K., Lord C., Lincoln A.J., Pizzo S., Schreibman L., Haas R.H., Akshoomoff N.A., Courchesne R.Y. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001, 57:245-254.
55. Cox D.R. Mouse trisomy 16 as an animal model of human trisomy 21: a new approach for studying the pathogenesis of Down syndrome. Mead Johnson Symp. Perinat. Dev. Med. 1983, 23-27.
56. Crawley J.N. Translational animal models of autism and neurodevelopmental disorders. Dialog. Clin. Neurosci. 2012, 14:293-305.
57. Cuneo B.F., Driscoll D.A., Gidding S.S., Langman C.B. Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. Am. J. Med. Genet. 1997, 69:50-55.
58. da Silva Alves F., Schmitz N., Bloemen O., van der Meer J., Meijer J., Boot E., Nederveen A., de Haan L., Linszen D., van Amelsvoort T. White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia. Schizophr. Res. 2011, 132:75-83.
59. Darrow D.H., Harley C.M. Evaluation of swallowing disorders in children. Otolaryngol. Clin. North Am. 1998, 31:405-418.
60. Debbane M., Lazouret M., Lagioia A., Schneider M., Van De Ville D., Eliez S. Resting-state networks in adolescents with 22q11.2 deletion syndrome: associations with prodromal symptoms and executive functions. Schizophr. Res. 2012, 139:33-39.
61. Delorme R., Ey E., Toro R., Leboyer M., Gillberg C., Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat. Med. 2013, 19:685-694.
62. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 2004, 432:231-235.
63. Driscoll D.A., Budarf M.L., Emanuel B.S. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am. J. Hum. Genet. 1992, 50:924-933.
64. Dupe V., Lumsden A. Hindbrain patterning involves graded responses to retinoic acid signalling. Development 2001, 128:2199-2208.
65. Dyce O., McDonald-McGinn D., Kirschner R.E., Zackai E., Young K., Jacobs I.N. Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch. Otolaryngol. Head Neck Surg. 2002, 128:1408-1412.
66. Earls L.R., Fricke R.G., Yu J., Berry R.B., Baldwin L.T., Zakharenko S.S. Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia. J. Neurosci. 2012, 32:14132-14144.
67. Eicher P.S., McDonald-Mcginn D.M., Fox C.A., Driscoll D.A., Emanuel B.S., Zackai E.H. Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J. Pediatr. 2000, 137:158-164.
68. Elia J., Glessner J.T., Wang K., Takahashi N., Shtir C.J., Hadley D., Sleiman P.M., Zhang H., Kim C.E., Robison R., Lyon G.J., Flory J.H., Bradfield J.P., Imielinski M., Hou C., Frackelton E.C., Chiavacci R.M., Sakurai T., Rabin C., Middleton F.A., Thomas K.A., Garris M., Mentch F., Freitag C.M., Steinhausen H.C., Todorov A.A., Reif A., Rothenberger A., Franke B., Mick E.O., Roeyers H., Buitelaar J., Lesch K.P., Banaschewski T., Ebstein R.P., Mulas F., Oades R.D., Sergeant J., Sonuga-Barke E., Renner T.J., Romanos M., Romanos J., Warnke A., Walitza S., Meyer J., Palmason H., Seitz C., Loo S.K., Smalley S.L., Biederman J., Kent L., Asherson P., Anney R.J., Gaynor J.W., Shaw P., Devoto M., White P.S., Grant S.F., Buxbaum J.D., Rapoport J.L., Williams N.M., Nelson S.F., Faraone S.V., Hakonarson H. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat. Genet. 2012, 44:78-84.
69. Etherton M.R., Blaiss C.A., Powell C.M., Sudhof T.C. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17998-18003.
70. Fan J.B., Chen W.Y., Tang J.X., Li S., Gu N.F., Feng G.Y., Breen G., St Clair D., He L. Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population. Mol. Psychiatry 2002, 7:446-447.
71. Fenelon K., Mukai J., Xu B., Hsu P.K., Drew L.J., Karayiorgou M., Fischbach G.D., Macdermott A.B., Gogos J.A. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4447-4452.
72. Fenelon K., Xu B., Lai C.S., Mukai J., Markx S., Stark K.L., Hsu P.K., Gan W.B., Fischbach G.D., MacDermott A.B., Karayiorgou M., Gogos J.A. The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion. J. Neurosci. 2013, 33:14825-14839.
73. Fernandez A., Meechan D., Baker J.L., Karpinski B.A., LaMantia A.S., Maynard T.M. 22q11 deletion syndrome: copy number variations and development. Principles of Developmental Genetics 2014, 677-696. Elsevier Academic Press, Amsterdam. S.A. Moody (Ed.).
74. Fietz S.A., Kelava I., Vogt J., Wilsch-Brauninger M., Stenzel D., Fish J.L., Corbeil D., Riehn A., Distler W., Nitsch R., Huttner W.B. OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling. Nat. Neurosci. 2010, 13:690-699.
75. Frank D.U., Fotheringham L.K., Brewer J.A., Muglia L.J., Tristani-Firouzi M., Capecchi M.R., Moon A.M. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 2002, 129:4591-4603.
76. Freund T.F., Katona I. Perisomatic inhibition. Neuron 2007, 56:33-42.
77. Friedman M.A., Miletta N., Roe C., Wang D., Morrow B.E., Kates W.R., Higgins A.M., Shprintzen R.J. Cleft palate, retrognathia and congenital heart disease in velo-cardio-facial syndrome: a phenotype correlation study. Int. J. Pediatr. Otorhinolaryngol. 2011, 75:1167-1172.
78. Fuchs J.C., Zinnamon F.A., Taylor R.R., Ivins S., Scambler P.J., Forge A., Tucker A.S., Linden J.F. Hearing loss in a mouse model of 22q11.2 Deletion Syndrome. PLoS ONE 2013, 8:e80104.
79. Funato N., Nakamura M., Richardson J.A., Srivastava D., Yanagisawa H. Tbx1 regulates oral epithelial adhesion and palatal development. Hum. Mol. Genet. 2012, 21:2524-2537.
80. Garg S.K., Lioy D.T., Cheval H., McGann J.C., Bissonnette J.M., Murtha M.J., Foust K.D., Kaspar B.K., Bird A., Mandel G. Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J. Neurosci. 2013, 33:13612-13620.
81. Gerdes M., Solot C., Wang P.P., McDonald-McGinn D.M., Zackai E.H. Taking advantage of early diagnosis: preschool children with the 22q11.2 deletion. Genet. Med. 2001, 3:40-44.
82. Gerkes E.H., Hordijk R., Dijkhuizen T., Sival D.A., Meiners L.C., Sikkema-Raddatz B., van Ravenswaaij-Arts C.M. Bilateral polymicrogyria as the indicative feature in a child with a 22q11.2 deletion. Eur. J. Med. Genet. 2010, 53:344-346.
83. Geschwind D.H., Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 2007, 17:103-111.
84. Geschwind D.H., Boone K.B., Miller B.L., Swerdloff R.S. Neurobehavioral phenotype of Klinefelter syndrome. Ment Retard. Dev. Disabil. Res. Rev. 2000, 6:107-116.
85. Giusti-Rodriguez P., Sullivan P.F. The genomics of schizophrenia: update and implications. J. Clin. Invest. 2013, 123:4557-4563.
86. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
87. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., Imielinski M., Frackelton E.C., Reichert J., Crawford E.L., Munson J., Sleiman P.M., Chiavacci R., Annaiah K., Thomas K., Hou C., Glaberson W., Flory J., Otieno F., Garris M., Soorya L., Klei L., Piven J., Meyer K.J., Anagnostou E., Sakurai T., Game R.M., Rudd D.S., Zurawiecki D., McDougle C.J., Davis L.K., Miller J., Posey D.J., Michaels S., Kolevzon A., Silverman J.M., Bernier R., Levy S.E., Schultz R.T., Dawson G., Owley T., McMahon W.M., Wassink T.H., Sweeney J.A., Nurnberger J.I., Coon H., Sutcliffe J.S., Minshew N.J., Grant S.F., Bucan M., Cook E.H., Buxbaum J.D., Devlin B., Schellenberg G.D., Hakonarson H. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
88. Glover J.C., Renaud J.S., Rijli F.M. Retinoic acid and hindbrain patterning. J. Neurobiol. 2006, 66:705-725.
89. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9991-9996.
90. Gong W., Emanuel B.S., Galili N., Kim D.H., Roe B., Driscoll D.A., Budarf M.L. Structural and mutational analysis of a conserved gene (DGSI) from the minimal DiGeorge syndrome critical region. Hum. Mol. Genet. 1997, 6:267-276.
91. Gothelf D., Presburger G., Zohar A.H., Burg M., Nahmani A., Frydman M., Shohat M., Inbar D., Aviram-Goldring A., Yeshaya J., Steinberg T., Finkelstein Y., Frisch A., Weizman A., Apter A. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am. J. Med. Genet. B: Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatric Genet. 2004, 126B:99-105.
92. Gothelf D., Hoeft F., Hinard C., Hallmayer J.F., Stoecker J.V., Antonarakis S.E., Morris M.A., Reiss A.L. Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome. Hum. Brain Mapp. 2007, 28:533-542.
93. Gothelf D., Hoeft F., Ueno T., Sugiura L., Lee A.D., Thompson P., Reiss A.L. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome. J. Psychiatr. Res. 2011, 45:322-331.
94. Gotter A.L., Shaikh T.H., Budarf M.L., Rhodes C.H., Emanuel B.S. A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2. Hum. Mol. Genet. 2004, 13:103-115.
95. Goudy S., Law A., Sanchez G., Baldwin H.S., Brown C. Tbx1 is necessary for palatal elongation and elevation. Mech. Dev. 2010, 127:292-300.
96. Grayton H.M., Missler M., Collier D.A., Fernandes C. Altered social behaviours in neurexin 1alpha knockout mice resemble core symptoms in neurodevelopmental disorders. PLoS ONE 2013, 8:e67114.
97. Griffin H.R., Topf A., Glen E., Zweier C., Stuart A.G., Parsons J., Peart I., Deanfield J., O'Sullivan J., Rauch A., Scambler P., Burn J., Cordell H.J., Keavney B., Goodship J.A. Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart 2010, 96:1651-1655.
98. Guarguaglini G., Battistoni A., Pittoggi C., Di Matteo G., Di Fiore B., Lavia P. Expression of the murine RanBP1 and Htf9-c genes is regulated from a shared bidirectional promoter during cell cycle progression. Biochem. J. 1997, 325(Pt 1):277-286.
99. Guidi C.J., Veal T.M., Jones S.N., Imbalzano A.N. Transcriptional compensation for loss of an allele of the Ini1 tumor suppressor. J. Biol. Chem. 2004, 279:4180-4185.
100. Guo C., Sun Y., Zhou B., Adam R.M., Li X., Pu W.T., Morrow B.E., Moon A., Li X. A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis. J. Clin. Investig. 2011, 121:1585-1595.
101. Guo T., McDonald-McGinn D., Blonska A., Shanske A., Bassett A.S., Chow E., Bowser M., Sheridan M., Beemer F., Devriendt K., Swillen A., Breckpot J., Digilio M.C., Marino B., Dallapiccola B., Carpenter C., Zheng X., Johnson J., Chung J., Higgins A.M., Philip N., Simon T.J., Coleman K., Heine-Suner D., Rosell J., Kates W., Devoto M., Goldmuntz E., Zackai E., Wang T., Shprintzen R., Emanuel B., Morrow B. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients. Hum. Mutat. 2011, 32:1278-1289.
102. Guo X., Freyer L., Morrow B., Zheng D. Characterization of the past and current duplication activities in the human 22q11.2 region. BMC Genomics 2011, 12:71.
103. Guris D.L., Duester G., Papaioannou V.E., Imamoto A. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev. Cell 2006, 10:81-92.
104. Guthrie S. Patterning and axon guidance of cranial motor neurons. Nat. Rev. Neurosci. 2007, 8:859-871.
105. Guy J.D., Majorski L.V., Wallace C.J., Guy M.P. The incidence of minor physical anomalies in adult male schizophrenics. Schizophr. Bull. 1983, 9:571-582.
106. Haar S., Berman S., Behrmann M., Dinstein I. Anatomical abnormalities in autism?. Cereb. Cortex 2014, Epub ahead of print.
107. Halford S., Lindsay E., Nayudu M., Carey A.H., Baldini A., Scambler P.J. Low-copy-number repeat sequences flank the DiGeorge/velo-cardio-facial syndrome loci at 22q11. Hum. Mol. Genet. 1993, 2:191-196.
108. Hansen D.V., Lui J.H., Parker P.R., Kriegstein A.R. Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature 2010, 464:554-561.
109. Harper K.M., Hiramoto T., Tanigaki K., Kang G., Suzuki G., Trimble W., Hiroi N. Alterations of social interaction through genetic and environmental manipulation of the 22q11.2 gene Sept5 in the mouse brain. Hum. Mol. Genet. 2012, 21:3489-3499.
110. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 2003, 23:6315-6326.
111. Haydar T.F., Reeves R.H. Trisomy 21 and early brain development. Trends Neurosci. 2012, 35:81-91.
112. Hazlett H.C., Poe M.D., Gerig G., Smith R.G., Piven J. Cortical gray and white brain tissue volume in adolescents and adults with autism. Biol. Psychiatry 2006, 59:1-6.
113. Hazlett E.A., Romero M.J., Haznedar M.M., New A.S., Goldstein K.E., Newmark R.E., Siever L.J., Buchsbaum M.S. Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr. Res. 2007, 93:288-295.
114. Herman S.B., Guo T., McGinn D.M., Blonska A., Shanske A.L., Bassett A.S., Chow E.W., Bowser M., Sheridan M., Beemer F., Devriendt K., Swillen A., Breckpot J., Digilio M.C., Marino B., Dallapiccola B., Carpenter C., Zheng X., Johnson J., Chung J., Higgins A.M., Philip N., Simon T., Coleman K., Heine-Suner D., Rosell J., Kates W., Devoto M., Zackai E., Wang T., Shprintzen R., Emanuel B.S., Morrow B.E. Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients. Am. J. Med. Genet. A 2012, 158A:2781-2787.
115. Hevner R.F. From radial glia to pyramidal-projection neuron: transcription factor cascades in cerebral cortex development. Mol. Neurobiol. 2006, 33:33-50.
116. Hoischen A., Krumm N., Eichler E.E. Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat. Neurosci. 2014, 17:764-772.
117. Horn A., Ostwald D., Reisert M., Blankenburg F. The structural-functional connectome and the default mode network of the human brain. Neuroimage 2014, 102:142-151.
118. Hurles M.E., Lupiski J.R. Recombination hotspots in nonallelic homologous recombination. Genomic Disorders: The Genomic Basis of Disease 2006, 341-355. Humana Press, Totowa, NJ. J.R. Lupiski, P.T. Stankiewicz (Eds.).
119. Hutsler J.J., Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 2010, 1309:83-94.
120. Inan M., Petros T.J., Anderson S.A. Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia. Neurobiol. Dis. 2013, 53:36-48.
121. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
122. Jacquet H., Raux G., Thibaut F., Hecketsweiler B., Houy E., Demilly C., Haouzir S., Allio G., Fouldrin G., Drouin V., Bou J., Petit M., Campion D., Frebourg T. PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum. Mol. Genet. 2002, 11:2243-2249.
123. Jalbrzikowski M., Jonas R., Senturk D., Patel A., Chow C., Green M.F., Bearden C.E. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: relationship with psychotic symptoms. Neuroimage Clin. 2013, 3:405-415.
124. Jalbrzikowski M., Villalon-Reina J.E., Karlsgodt K.H., Senturk D., Chow C., Thompson P.M., Bearden C.E. Altered white matter microstructure is associated with social cognition and psychotic symptoms in 22q11.2 microdeletion syndrome. Front. Behav. Neurosci. 2014, 8:393.
125. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 2001, 27:286-291.
126. Jeste S.S., Geschwind D.H. Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat. Rev. Neurol. 2014, 10:74-81.
127. Johnson E.S., Ma P.C., Ota I.M., Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 1995, 270:17442-17456.
128. Jonas R.K., Montojo C.A., Bearden C.E. The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. Biol. Psychiatry 2014, 75:351-360.
129. Just M.A., Cherkassky V.L., Keller T.A., Minshew N.J. Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain 2004, 127:1811-1821.
130. Karpinski B.A., Maynard T.M., Fralish M.S., Nuwayhid S., Zohn I.E., Moody S.A., LaMantia A.S. Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome. Dis. Models Mech. 2014, 7:245-257.
131. Kates W.R., Antshel K., Willhite R., Bessette B.A., AbdulSabur N., Higgins A.M. Gender-moderated dorsolateral prefrontal reductions in 22q11.2 Deletion Syndrome: implications for risk for schizophrenia. Child Neuropsychol. 2005, 11:73-85.
132. Kates W.R., Krauss B.R., Abdulsabur N., Colgan D., Antshel K.M., Higgins A.M., Shprintzen R.J. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome). Neuropsychologia 2007, 45:2863-2873.
133. Kates W.R., Olszewski A.K., Gnirke M.H., Kikinis Z., Nelson J., Antshel K.M., Fremont W., Radoeva P.D., Middleton F.A., Shenton M.E., Coman I.L. White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis. Schizophr. Res. 2015, 161:76-84.
134. Kawaguchi Y., Kubota Y. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb. Cortex 1997, 7:476-486.
135. Kehlenbach R.H., Dickmanns A., Kehlenbach A., Guan T., Gerace L. A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export. J. Cell Biol. 1999, 145:645-657.
136. Kelly D., Goldberg R., Wilson D., Lindsay E., Carey A., Goodship J., Burn J., Cross I., Shprintzen R.J., Scambler P.J. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am. J. Med. Genet. 1993, 45:308-312.
137. Kempf L., Nicodemus K.K., Kolachana B., Vakkalanka R., Verchinski B.A., Egan M.F., Straub R.E., Mattay V.A., Callicott J.H., Weinberger D.R., Meyer-Lindenberg A. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet. 2008, 4:e1000252.
138. Kennedy D.P., Redcay E., Courchesne E. Failing to deactivate: resting functional abnormalities in autism. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8275-8280.
139. Kenworthy L., Black D.O., Harrison B., della Rosa A., Wallace G.L. Are executive control functions related to autism symptoms in high-functioning children?. Child Neuropsychol. 2009, 15:425-440.
140. Kiehl T.R., Chow E.W., Mikulis D.J., George S.R., Bassett A.S. Neuropathologic features in adults with 22q11.2 deletion syndrome. Cereb. Cortex 2009, 19:153-164.
141. Kikinis Z., Asami T., Bouix S., Finn C.T., Ballinger T., Tworog-Dube E., Kucherlapati R., Kikinis R., Shenton M.E., Kubicki M. Reduced fractional anisotropy and axial diffusivity in white matter in 22q11.2 deletion syndrome: a pilot study. Schizophr. Res. 2012, 141:35-39.
142. Kirkpatrick J.A., DiGeorge A.M. Congenital absence of the thymus. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1968, 103:32-37.
143. Kowalczyk T., Pontious A., Englund C., Daza R.A., Bedogni F., Hodge R., Attardo A., Bell C., Huttner W.B., Hevner R.F. Intermediate neuronal progenitors (basal progenitors) produce pyramidal-projection neurons for all layers of cerebral cortex. Cereb. Cortex 2009, 19:2439-2450.
144. Kraynack N.C., Hostoffer R.W., Robin N.H. Agenesis of the corpus callosum associated with DiGeorge-velocardiofacial syndrome: a case report and review of the literature. J. Child Neurol. 1999, 14:754-756.
145. Kriegstein A.R., Gotz M. Radial glia diversity: a matter of cell fate. Glia 2003, 43:37-43.
146. Lai M.C., Lombardo M.V., Baron-Cohen S. Autism. Lancet 2014, 383:896-910.
147. LaMantia A.S. The usual suspects: GABA and glutamate may regulate proliferation in the neocortex. Neuron 1995, 15:1223-1225.
148. LaMonica B.E., Lui J.H., Wang X., Kriegstein A.R. OSVZ progenitors in the human cortex: an updated perspective on neurodevelopmental disease. Curr. Opin. Neurobiol. 2012, 22:747-753.
149. Lay-Son G., Palomares M., Guzman M.L., Vasquez M., Puga A., Repetto G.M. Palate abnormalities in Chilean patients with chromosome 22q11 microdeletion syndrome. Int. J. Pediatr. Otorhinolaryngol. 2012, 76:1726-1728.
150. Lee S.I., Jung H.Y., Kim S.H., Kim D.K., Mok J. Midline brain anomalies in a young schizophrenic patient with 22q11 deletion syndrome. Schizophr. Res. 2003, 60:323-325.
151. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
152. Lefton-Greif M.A. Pediatric dysphagia. Phys. Med. Rehabil. Clin. N. Am. 2008, 19:837-851. ix.
153. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000, 28:325-334.
154. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6:312-324.
155. Lewis D.A., Curley A.A., Glausier J.R., Volk D.W. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012, 35:57-67.
156. Li T., Ma X., Sham P.C., Sun X., Hu X., Wang Q., Meng H., Deng W., Liu X., Murray R.M., Collier D.A. Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population. Am. J. Med. Genet. B: Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatric Genet. 2004, 129B:13-15.
157. Liao J., Kochilas L., Nowotschin S., Arnold J.S., Aggarwal V.S., Epstein J.A., Brown M.C., Adams J., Morrow B.E. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum. Mol. Genet. 2004, 13:1577-1585.
158. Lindsay E.A., Botta A., Jurecic V., Carattini-Rivera S., Cheah Y.C., Rosenblatt H.M., Bradley A., Baldini A. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 1999, 401:379-383.
159. Lindsay E.A., Vitelli F., Su H., Morishima M., Huynh T., Pramparo T., Jurecic V., Ogunrinu G., Sutherland H.F., Scambler P.J., Bradley A., Baldini A. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410:97-101.
160. Liu J.S. Molecular genetics of neuronal migration disorders. Curr. Neurol. Neurosci. Rep. 2011, 11:171-178.
161. Liu H., Abecasis G.R., Heath S.C., Knowles A., Demars S., Chen Y.J., Roos J.L., Rapoport J.L., Gogos J.A., Karayiorgou M. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16859-16864.
162. Liu H., Heath S.C., Sobin C., Roos J.L., Galke B.L., Blundell M.L., Lenane M., Robertson B., Wijsman E.M., Rapoport J.L., Gogos J.A., Karayiorgou M. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3717-3722.
163. Llevadot R., Marques G., Pritchard M., Estivill X., Ferrus A., Scambler P. Cloning, chromosome mapping and expression analysis of the HIRA gene from Drosophila melanogaster. Biochem. Biophys. Res. Commun. 1998, 249:486-491.
164. Long J.M., Laporte P., Merscher S., Funke B., Saint-Jore B., Puech A., Kucherlapati R., Morrow B.E., Skoultchi A.I., Wynshaw-Boris A. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 2006, 7:247-257.
165. Loo S.K., Hale T.S., Macion J., Hanada G., McGough J.J., McCracken J.T., Smalley S.L. Cortical activity patterns in ADHD during arousal, activation and sustained attention. Neuropsychologia 2009, 47:2114-2119.
166. Lord C., Risi S., DiLavore P.S., Shulman C., Thurm A., Pickles A. Autism from 2 to 9 years of age. Arch. Gen. Psychiatry 2006, 63:694-701.
167. LoTurco J.J., Owens D.F., Heath M.J., Davis M.B., Kriegstein A.R. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1995, 15:1287-1298.
168. Lui J.H., Hansen D.V., Kriegstein A.R. Development and evolution of the human neocortex. Cell 2011, 146:18-36.
169. Luo R., Sanders S.J., Tian Y., Voineagu I., Huang N., Chu S.H., Klei L., Cai C., Ou J., Lowe J.K., Hurles M.E., Devlin B., State M.W., Geschwind D.H. Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am. J. Hum. Genet. 2012, 91:38-55.
170. Marin O. Interneuron dysfunction in psychiatric disorders. Nat. Rev. Neurosci. 2012, 13:107-120.
171. Markram H., Toledo-Rodriguez M., Wang Y., Gupta A., Silberberg G., Wu C. Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 2004, 5:793-807.
172. Marshall H., Nonchev S., Sham M.H., Muchamore I., Lumsden A., Krumlauf R. Retinoic acid alters hindbrain Hox code and induces transformation of rhombomeres 2/3 into a 4/5 identity. Nature 1992, 360:737-741.
173. Mas S., Bernardo M., Parellada E., Garcia-Rizo C., Gasso P., Alvarez S., Lafuente A. ARVCF single marker and haplotypic association with schizophrenia. Progress Neuro-psychopharmacol. Biol. Psychiatry 2009, 33:1064-1069.
174. Maynard T.M., Haskell G.T., Bhasin N., Lee J.M., Gassman A.A., Lieberman J.A., LaMantia A.S. RanBP1, a velocardiofacial/DiGeorge syndrome candidate gene, is expressed at sites of mesenchymal/epithelial induction. Mech. Dev. 2002, 111:177-180.
175. Maynard T.M., Haskell G.T., Peters A.Z., Sikich L., Lieberman J.A., LaMantia A.S. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14433-14438.
176. Maynard T.M., Meechan D.W., Heindel C.C., Peters A.Z., Hamer R.M., Lieberman J.A., LaMantia A.S. No evidence for parental imprinting of mouse 22q11 gene orthologs. Mamm. Genome 2006, 17:822-832.
177. Maynard T.M., Meechan D.W., Dudevoir M.L., Gopalakrishna D., Peters A.Z., Heindel C.C., Sugimoto T.J., Wu Y., Lieberman J.A., Lamantia A.S. Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. Mol. Cell. Neurosci. 2008, 39:439-451.
178. Maynard T.M., Gopalakrishna D., Meechan D.W., Paronett E.M., Newbern J.M., LaMantia A.S. 22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development. Hum. Mol. Genet. 2013, 22:300-312.
179. McAlonan G.M., Cheung V., Cheung C., Suckling J., Lam G.Y., Tai K.S., Yip L., Murphy D.G., Chua S.E. Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 2005, 128:268-276.
180. McCabe K.L., Atkinson R.J., Cooper G., Melville J.L., Harris J., Schall U., Loughland C.M., Thienel R., Campbell L.E. Pre-pulse inhibition and antisaccade performance indicate impaired attention modulation of cognitive inhibition in 22q11.2 deletion syndrome (22q11DS). J. Neurodev. Disord. 2014, 6:38.
181. McDonald-McGinn D.M., Sullivan K.E. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011, 90:1-18.
182. McDonald-McGinn D.M., Emanuel B.S., Zackai E.H. 22q11.2 deletion syndrome. Gene Reviews 1993, Seattle, WA. R.A. Pagon, M.P. Adam, T.D. Bird, C.R. Dolan, C.T. Fong, K. Stephens (Eds.).
183. McDonald-McGinn D.M., Tonnesen M.K., Laufer-Cahana A., Finucane B., Driscoll D.A., Emanuel B.S., Zackai E.H. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!. Genet. Med. 2001, 3:23-29.
184. McLennan Y., Polussa J., Tassone F., Hagerman R. Fragile x syndrome. Curr. Genomics 2011, 12:216-224.
185. McManus M.F., Golden J.A. Neuronal migration in developmental disorders. J. Child Neurol. 2005, 20:280-286.
186. Meechan D.W., Maynard T.M., Wu Y., Gopalakrishna D., Lieberman J.A., LaMantia A.S. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. Mol. Cell. Neurosci. 2006, 33:412-428.
187. Meechan D.W., Tucker E.S., Maynard T.M., LaMantia A.S. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16434-16445.
188. Meechan D.W., Tucker E.S., Maynard T.M., LaMantia A.S. Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:18601-18606.
189. Meechan D.W., Rutz H.L., Fralish M.S., Maynard T.M., Rothblat L.A., Lamantia A.S. Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS. Cereb. Cortex 2015, 25:1143-1151.
190. Merscher S., Funke B., Epstein J.A., Heyer J., Puech A., Lu M.M., Xavier R.J., Demay M.B., Russell R.G., Factor S., Tokooya K., Jore B.S., Lopez M., Pandita R.K., Lia M., Carrion D., Xu H., Schorle H., Kobler J.B., Scambler P., Wynshaw-Boris A., Skoultchi A.I., Morrow B.E., Kucherlapati R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
191. Ming J.E., McDonald-McGinn D.M., Megerian T.E., Driscoll D.A., Elias E.R., Russell B.M., Irons M., Emanuel B.S., Markowitz R.I., Zackai E.H. Skeletal anomalies and deformities in patients with deletions of 22q11. Am. J. Med. Genet. 1997, 72:210-215.
192. Miyamoto S., Miyake N., Jarskog L.F., Fleischhacker W.W., Lieberman J.A. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol. Psychiatry 2012, 17:1206-1227.
193. Molina O., Anton E., Vidal F., Blanco J. Sperm rates of 7q11.23, 15q11q13 and 22q11.2 deletions and duplications: a FISH approach. Hum. Genet. 2011, 129:35-44.
194. Molnar Z., Clowry G. Cerebral cortical development in rodents and primates. Prog. Brain Res. 2012, 195:45-70.
195. Montojo C.A., Jalbrzikowski M., Congdon E., Domicoli S., Chow C., Dawson C., Karlsgodt K.H., Bilder R.M., Bearden C.E. Neural substrates of inhibitory control deficits in 22q11.2 deletion syndrome. Cereb. Cortex 2015, 25:1069-1079.
196. Montojo C.A., Ibrahim A., Karlsgodt K.H., Chow C., Hilton A.E., Jonas R.K., Vesagas T.K., Bearden C.E. Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome. Neuroimage Clin. 2014, 4:392-402.
197. Monyer H., Markram H. Interneuron diversity series: molecular and genetic tools to study GABAergic interneuron diversity and function. Trends Neurosci. 2004, 27:90-97.
198. Mori T., Mori K., Fujii E., Toda Y., Miyazaki M., Harada M., Kagami S. Neuroradiological and neurofunctional examinations for patients with 22q11.2 deletion. Neuropediatrics 2011, 42:215-221.
199. Moyer S.E., Lewis P.W., Botchan M.R. Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10236-10241.
200. Mueller S., Keeser D., Samson A.C., Kirsch V., Blautzik J., Grothe M., Erat O., Hegenloh M., Coates U., Reiser M.F., Hennig-Fast K., Meindl T. Convergent findings of altered functional and structural brain connectivity in individuals with high functioning autism: a multimodal MRI study. PLoS ONE 2013, 8:e67329.
201. Mueller W., Schutz D., Nagel F., Schulz S., Stumm R. Hierarchical organization of multi-site phosphorylation at the CXCR4C terminus. PLoS ONE 2013, 8:e64975.
202. Mukai J., Liu H., Burt R.A., Swor D.E., Lai W.S., Karayiorgou M., Gogos J.A. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 2004, 36:725-731.
203. Mukai J., Dhilla A., Drew L.J., Stark K.L., Cao L., MacDermott A.B., Karayiorgou M., Gogos J.A. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 2008, 11:1302-1310.
204. Murphy K.C., Jones L.A., Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 1999, 56:940-945.
205. Nagai M., Moriyama T., Mehmood R., Tokuhiro K., Ikawa M., Okabe M., Tanaka H., Yoneda Y. Mice lacking Ran binding protein 1 are viable and show male infertility. FEBS Lett. 2011, 585:791-796.
206. Nakamura M., Nestor P.G., McCarley R.W., Levitt J.J., Hsu L., Kawashima T., Niznikiewicz M., Shenton M.E. Altered orbitofrontal sulcogyral pattern in schizophrenia. Brain 2007, 130:693-707.
207. Niederreither K., Vermot J., Schuhbaur B., Chambon P., Dolle P. Retinoic acid synthesis and hindbrain patterning in the mouse embryo. Development 2000, 127:75-85.
208. Niklasson L., Rasmussen P., Oskarsdottir S., Gillberg C. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res. Dev. Disabil. 2009, 30:763-773.
209. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
210. Noctor S.C., Martinez-Cerdeno V., Kriegstein A.R. Contribution of intermediate progenitor cells to cortical histogenesis. Arch. Neurol. 2007, 64:639-642.
211. Noel A.C., Pelluard F., Delezoide A.L., Devisme L., Loeuillet L., Leroy B., Martin A., Bouvier R., Laquerriere A., Jeanne-Pasquier C., Bessieres-Grattagliano B., Mechler C., Alanio E., Leroy C., Gaillard D. Fetal phenotype associated with the 22q11 deletion. Am. J. Med. Genet. A. 2014, 164:2724-2731.
212. Nordahl C.W., Dierker D., Mostafavi I., Schumann C.M., Rivera S.M., Amaral D.G., Van Essen D.C. Cortical folding abnormalities in autism revealed by surface-based morphometry. J. Neurosci. 2007, 27:11725-11735.
213. Nowotschin S., Liao J., Gage P.J., Epstein J.A., Campione M., Morrow B.E. Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. Development 2006, 133:1565-1573.
214. Okugawa G., Tamagaki C., Agartz I. Frontal and temporal volume size of grey and white matter in patients with schizophrenia: an MRI parcellation study. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:304-307.
215. Ota V.K., Bellucco F.T., Gadelha A., Santoro M.L., Noto C., Christofolini D.M., Assuncao I.B., Yamada K.M., Ribeiro-dos-Santos A.K., Santos S., Mari J.J., Smith M.A., Melaragno M.I., Bressan R.A., Sato J.R., Jackowski A.P., Belangero S.I. PRODH polymorphisms, cortical volumes and thickness in schizophrenia. PLOS ONE 2014, 9:e87686.
216. Ottet M.C., Schaer M., Cammoun L., Schneider M., Debbane M., Thiran J.P., Eliez S. Reduced fronto-temporal and limbic connectivity in the 22q11.2 deletion syndrome: vulnerability markers for developing schizophrenia?. PLoS ONE 2013, 8:e58429.
217. Papangeli I., Scambler P.J. Tbx1 genetically interacts with the transforming growth factor-beta/bone morphogenetic protein inhibitor Smad7 during great vessel remodeling. Circ. Res. 2013, 112:90-102.
218. Paranaiba L.M., de Aquino S.N., Bufalino A., Martelli-Junior H., Graner E., Brito L.A., Passos-Bueno M.R., Coletta R.D., Swerts M.S. Contribution of polymorphisms in genes associated with craniofacial development to the risk of nonsyndromic cleft lip and/or palate in the Brazilian population. Med. Oral Patol. Oral Cir. Bucal 2013, 18:e414-e420.
219. Parikshak N.N., Luo R., Zhang A., Won H., Lowe J.K., Chandran V., Horvath S., Geschwind D.H. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.
220. Paronett E.M., Meechan D., Karpinski B.A., LaMantia A.S., Maynard T.M. Ranbp1, deleted in DiGeorge/22q11.2 deletion syndrome, is a microcephaly gene that selectively disrupts layer 2/3 cortical projection neuron generation. Cereb. Cortex 2014, (in press).
221. Paterlini M., Zakharenko S.S., Lai W.S., Qin J., Zhang H., Mukai J., Westphal K.G., Olivier B., Sulzer D., Pavlidis P., Siegelbaum S.A., Karayiorgou M., Gogos J.A. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat. Neurosci. 2005, 8:1586-1594.
222. Paylor R., McIlwain K.L., McAninch R., Nellis A., Yuva-Paylor L.A., Baldini A., Lindsay E.A. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum. Mol. Genet. 2001, 10:2645-2650.
223. Paylor R., Glaser B., Mupo A., Ataliotis P., Spencer C., Sobotka A., Sparks C., Choi C.H., Oghalai J., Curran S., Murphy K.C., Monks S., Williams N., O'Donovan M.C., Owen M.J., Scambler P.J., Lindsay E. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7729-7734.
224. Pfeiffer B.E., Zang T., Wilkerson J.R., Taniguchi M., Maksimova M.A., Smith L.N., Cowan C.W., Huber K.M. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 2010, 66:191-197.
225. Phillips O.R., Nuechterlein K.H., Asarnow R.F., Clark K.A., Cabeen R., Yang Y., Woods R.P., Toga A.W., Narr K.L. Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability. Biol. Psychiatry 2011, 70:680-689.
226. Pierri J.N., Volk C.L., Auh S., Sampson A., Lewis D.A. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry 2001, 58:466-473.
227. Prasad S., Katina S., Hennessy R.J., Murphy K.C., Bowman A.W., Waddington J.L. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis. Am. J. Med. Genet. A 2015, 167:529-536.
228. Puech A., Saint-Jore B., Funke B., Gilbert D.J., Sirotkin H., Copeland N.G., Jenkins N.A., Kucherlapati R., Morrow B., Skoultchi A.I. Comparative mapping of the human 22q11 chromosomal region and the orthologous region in mice reveals complex changes in gene organization. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14608-14613.
229. Pulver A.E., Nestadt G., Goldberg R., Shprintzen R.J., Lamacz M., Wolyniec P.S., Morrow B., Karayiorgou M., Antonarakis S.E., Housman D., et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J. Nerv. Ment. Dis. 1994, 182:476-478.
230. Radoeva P.D., Coman I.L., Antshel K.M., Fremont W., McCarthy C.S., Kotkar A., Wang D., Shprintzen R.J., Kates W.R. Atlas-based white matter analysis in individuals with velo-cardio-facial syndrome (22q11.2 deletion syndrome) and unaffected siblings. Behav. Brain Funct. 2012, 8:38.
231. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
232. Rauch R., Hofbeck M., Zweier C., Koch A., Zink S., Trautmann U., Hoyer J., Kaulitz R., Singer H., Rauch A. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J. Med. Genet. 2010, 47:321-331.
233. Raymond G.V., Bauman M.L., Kemper T.L. Hippocampus in autism: a Golgi analysis. Acta Neuropathol. 1996, 91:117-119.
234. Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., Schmidt C., Bronson R.T., Davisson M.T. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 1995, 11:177-184.
235. Roberts C., Sutherland H.F., Farmer H., Kimber W., Halford S., Carey A., Brickman J.M., Wynshaw-Boris A., Scambler P.J. Targeted mutagenesis of the Hira gene results in gastrulation defects and patterning abnormalities of mesoendodermal derivatives prior to early embryonic lethality. Mol. Cell. Biol. 2002, 22:2318-2328.
236. Robin N.H., Shprintzen R.J. Defining the clinical spectrum of deletion 22q11.2. J. Pediatr. 2005, 147:90-96.
237. Robin N.H., Taylor C.J., McDonald-McGinn D.M., Zackai E.H., Bingham P., Collins K.J., Earl D., Gill D., Granata T., Guerrini R., Katz N., Kimonis V., Lin J.P., Lynch D.R., Mohammed S.N., Massey R.F., McDonald M., Rogers R.C., Splitt M., Stevens C.A., Tischkowitz M.D., Stoodley N., Leventer R.J., Pilz D.T., Dobyns W.B. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am. J. Med. Genet. A 2006, 140:2416-2425.
238. Rommel N., Davidson G., Cain T., Hebbard G., Omari T. Videomanometric evaluation of pharyngo-oesophageal dysmotility in children with velocardiofacial syndrome. J. Pediatr. Gastroenterol. Nutr. 2008, 46:87-91.
239. Ronesi J.A., Collins K.A., Hays S.A., Tsai N.P., Guo W., Birnbaum S.G., Hu J.H., Worley P.F., Gibson J.R., Huber K.M. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat. Neurosci. 2012, 15:431-440. S431.
240. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003, 2:255-267.
241. Rutz H.L., Rothblat L.A. Intact and impaired executive abilities in the BTBR mouse model of autism. Behav. Brain Res. 2012, 234:33-37.
242. Ryan A.K., Goodship J.A., Wilson D.I., Philip N., Levy A., Seidel H., Schuffenhauer S., Oechsler H., Belohradsky B., Prieur M., Aurias A., Raymond F.L., Clayton-Smith J., Hatchwell E., McKeown C., Beemer F.A., Dallapiccola B., Novelli G., Hurst J.A., Ignatius J., Green A.J., Winter R.M., Brueton L., Brondum-Nielsen K., Scambler P.J., et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 1997, 34:798-804.
243. Sanders A.R., Rusu I., Duan J., Vander Molen J.E., Hou C., Schwab S.G., Wildenauer D.B., Martinez M., Gejman P.V. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol. Psychiatry 2005, 10:353-365.
244. Sarnat H.B., Flores-Sarnat L. Radial microcolumnar cortical architecture: maturational arrest or cortical dysplasia?. Pediatr. Neurol. 2013, 48:259-270.
245. Scambler P.J. 22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development. Pediatr. Cardiol. 2010, 31:378-390.
246. Schaer M., Schmitt J.E., Glaser B., Lazeyras F., Delavelle J., Eliez S. Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study. Psychiatry Res. 2006, 146:1-11.
247. Schaer M., Debbane M., Bach Cuadra M., Ottet M.C., Glaser B., Thiran J.P., Eliez S. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study. Schizophr. Res. 2009, 115:182-190.
248. Schaer M., Glaser B., Cuadra M.B., Debbane M., Thiran J.P., Eliez S. Congenital heart disease affects local gyrification in 22q11.2 deletion syndrome. Dev. Med. Child Neurol. 2009, 51:746-753.
249. Schaer M., Glaser B., Ottet M.C., Schneider M., Bach Cuadra M., Debbane M., Thiran J.P., Eliez S. Regional cortical volumes and congenital heart disease: a MRI study in 22q11.2 deletion syndrome. J. Neurodev. Disord. 2010, 2:224-234.
250. Schneider M., Debbane M., Bassett A.S., Chow E.W., Fung W.L., van den Bree M., Owen M., Murphy K.C., Niarchou M., Kates W.R., Antshel K.M., Fremont W., McDonald-McGinn D.M., Gur R.E., Zackai E.H., Vorstman J., Duijff S.N., Klaassen P.W., Swillen A., Gothelf D., Green T., Weizman A., Van Amelsvoort T., Evers L., Boot E., Shashi V., Hooper S.R., Bearden C.E., Jalbrzikowski M., Armando M., Vicari S., Murphy D.G., Ousley O., Campbell L.E., Simon T.J., Eliez S. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am. J. Psychiatry 2014, 171:627-639.
251. Schreiner M.J., Karlsgodt K.H., Uddin L.Q., Chow C., Congdon E., Jalbrzikowski M., Bearden C.E. Default mode network connectivity and reciprocal social behavior in 22q11.2 deletion syndrome. Soc. Cogn. Affect. Neurosci. 2014, 9:1261-1267.
252. Seidman L.J., Biederman J., Liang L., Valera E.M., Monuteaux M.C., Brown A., Kaiser J., Spencer T., Faraone S.V., Makris N. Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol. Psychiatry 2011, 69:857-866.
253. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Compar. Neurol. 1998, 392:402-412.
254. Selemon L.D., Kleinman J.E., Herman M.M., Goldman-Rakic P.S. Smaller frontal gray matter volume in postmortem schizophrenic brains. Am. J. Psychiatry 2002, 159:1983-1991.
255. Sellier C., Hwang V.J., Dandekar R., Durbin-Johnson B., Charlet-Berguerand N., Ander B.P., Sharp F.R., Angkustsiri K., Simon T.J., Tassone F. Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome. PLOS ONE 2014, 9:e103884.
256. Sessa A., Mao C.A., Hadjantonakis A.K., Klein W.H., Broccoli V. Tbr2 directs conversion of radial glia into basal precursors and guides neuronal amplification by indirect neurogenesis in the developing neocortex. Neuron 2008, 60:56-69.
257. Severance E.G., Yolken R.H., Eaton W.W. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr. Res. 2014, Epub ahead of print.
258. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
259. Shahbazian M.D., Antalffy B., Armstrong D.L., Zoghbi H.Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 2002, 11:115-124.
260. Shaikh T.H., Kurahashi H., Saitta S.C., O'Hare A.M., Hu P., Roe B.A., Driscoll D.A., McDonald-McGinn D.M., Zackai E.H., Budarf M.L., Emanuel B.S. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum. Mol. Genet. 2000, 9:489-501.
261. Shaikh T.H., Kurahashi H., Emanuel B.S. Evolutionarily conserved low copy repeats (LCRs) in 22q11 mediate deletions, duplications, translocations, and genomic instability: an update and literature review. Genet. Med.: Off. J. Am. Coll. Med. Genet. 2001, 3:6-13.
262. Shaikh T.H., O'Connor R.J., Pierpont M.E., McGrath J., Hacker A.M., Nimmakayalu M., Geiger E., Emanuel B.S., Saitta S.C. Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms. Genome Res. 2007, 17:482-491.
263. Shashi V., Kwapil T.R., Kaczorowski J., Berry M.N., Santos C.S., Howard T.D., Goradia D., Prasad K., Vaibhav D., Rajarethinam R., Spence E., Keshavan M.S. Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Res. 2010, 181:1-8.
264. Shashi V., Veerapandiyan A., Keshavan M.S., Zapadka M., Schoch K., Kwapil T.R., Hooper S.R., Stanley J.A. Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol. Psychiatry 2012, 72:684-691.
265. Shaw P., Gogtay N., Rapoport J. Childhood psychiatric disorders as anomalies in neurodevelopmental trajectories. Hum. Brain Mapp. 2010, 31:917-925.
266. Shprintzen R.J., Goldberg R.B., Young D., Wolford L. The velo-cardio-facial syndrome: a clinical and genetic analysis. Pediatrics 1981, 67:167-172.
267. Shprintzen R.J., Higgins A.M., Antshel K., Fremont W., Roizen N., Kates W. Velo-cardio-facial syndrome. Curr. Opin. Pediatr. 2005, 17:725-730.
268. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464:763-767.
269. Silk T.J., Vance A., Rinehart N., Bradshaw J.L., Cunnington R. White-matter abnormalities in attention deficit hyperactivity disorder: a diffusion tensor imaging study. Hum. Brain Mapp. 2009, 30:2757-2765.
270. Sobin C., Monk S.H., Kiley-Brabeck K., Khuri J., Karayiorgou M. Neuromotor deficits in children with the 22q11 deletion syndrome. Mov. Disord. 2006, 21:2082-2089.
271. Srivastava S., Buonocore M.H., Simon T.J. Atypical developmental trajectory of functionally significant cortical areas in children with chromosome 22q11.2 deletion syndrome. Hum. Brain Mapp. 2012, 33:213-223.
272. Stark K.L., Xu B., Bagchi A., Lai W.S., Liu H., Hsu R., Wan X., Pavlidis P., Mills A.A., Karayiorgou M., Gogos J.A. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 2008, 40:751-760.
273. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Moller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Muhleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nothen M.M., Peltonen L., Collier D.A., St Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
274. Steffenburg S., Gillberg C.L., Steffenburg U., Kyllerman M. Autism in Angelman syndrome: a population-based study. Pediatr. Neurol. 1996, 14:131-136.
275. Stenman J., Toresson H., Campbell K. Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis. J. Neurosci. 2003, 23:167-174.
276. Stone J.M. Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia. Curr. Pharm. Des. 2009, 15:2594-2602.
277. Stone, Day J.M., Tsagaraki F., Valli H., McLean I., Lythgoe M.A., O'Gorman D.J., Barker R.L., McGuire G.J., Oasis P.K. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol. Psychiatry 2009, 66:533-539.
278. Stoner R., Chow M.L., Boyle M.P., Sunkin S.M., Mouton P.R., Roy S., Wynshaw-Boris A., Colamarino S.A., Lein E.S., Courchesne E. Patches of disorganization in the neocortex of children with autism. N. Engl. J. Med. 2014, 370:1209-1219.
279. Stumm R.K., Zhou C., Ara T., Lazarini F., Dubois-Dalcq M., Nagasawa T., Hollt V., Schulz S. CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 2003, 23:5123-5130.
280. Stumm R., Kolodziej A., Schulz S., Kohtz J.D., Hollt V. Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon. J. Compar. Neurol. 2007, 502:382-399.
281. Suzuki G., Harper K.M., Hiramoto T., Sawamura T., Lee M., Kang G., Tanigaki K., Buell M., Geyer M.A., Trimble W.S., Agatsuma S., Hiroi N. Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Hum. Mol. Genet. 2009, 18:1652-1660.
282. Takahashi N., Brooks H.L., Wade J.B., Liu W., Kondo Y., Ito S., Knepper M.A., Smithies O. Posttranscriptional compensation for heterozygous disruption of the kidney-specific NaK2Cl cotransporter gene. J. Am. Soc. Nephrol. 2002, 13:604-610.
283. Tang S.X., Yi J.J., Calkins M.E., Whinna D.A., Kohler C.G., Souders M.C., McDonald-McGinn D.M., Zackai E.H., Emanuel B.S., Gur R.C., Gur R.E. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol. Med. 2014, 44:1267-1277.
284. Tarquinio D.C., Jones M.C., Jones K.L., Bird L.M. Growth charts for 22q11 deletion syndrome. Am. J. Med. Genet. A 2012, 158A:2672-2681.
285. Tedeschi A., Ciciarello M., Mangiacasale R., Roscioli E., Rensen W.M., Lavia P. RANBP1 localizes a subset of mitotic regulatory factors on spindle microtubules and regulates chromosome segregation in human cells. J. Cell Sci. 2007, 120:3748-3761.
286. Tomasi D., Volkow N.D. Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder. Biol. Psychiatry 2012, 71:443-450.
287. Toritsuka M., Kimoto S., Muraki K., Landek-Salgado M.A., Yoshida A., Yamamoto N., Horiuchi Y., Hiyama H., Tajinda K., Keni N., Illingworth E., Iwamoto T., Kishimoto T., Sawa A., Tanigaki K. Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:17552-17557.
288. Torres-Juan L., Rosell J., Sanchez-de-la-Torre M., Fibla J., Heine-Suner D. Analysis of meiotic recombination in 22q11.2, a region that frequently undergoes deletions and duplications. BMC Med. Genet. 2007, 8:14.
289. Tran H.T., Delvaeye M., Verschuere V., Descamps E., Crabbe E., Van Hoorebeke L., McCrea P., Adriaens D., Van Roy F., Vleminckx K. ARVCF depletion cooperates with Tbx1 deficiency in the development of 22q11.2DS-like phenotypes in Xenopus. Dev. Dyn. 2011, 240:2680-2687.
290. Tucker E.S., Segall S., Gopalakrishna D., Wu Y., Vernon M., Polleux F., Lamantia A.S. Molecular specification and patterning of progenitor cells in the lateral and medial ganglionic eminences. J. Neurosci. 2008, 28:9504-9518.
291. van Amelsvoort T., Daly E., Henry J., Robertson D., Ng V., Owen M., Murphy K.C., Murphy D.G. Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch. Gen. Psychiatry 2004, 61:1085-1096.
292. van Bueren K.L., Papangeli I., Rochais F., Pearce K., Roberts C., Calmont A., Szumska D., Kelly R.G., Bhattacharya S., Scambler P.J. Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome. Dev. Biol. 2010, 340:369-380.
293. van Kogelenberg M., Ghedia S., McGillivray G., Bruno D., Leventer R., Macdermot K., Nelson J., Nagarajan L., Veltman J.A., de Brouwer A.P., McKinlay Gardner R.J., van Bokhoven H., Kirk E.P., Robertson S.P. Periventricular heterotopia in common microdeletion syndromes. Mol. Syndromol. 2010, 1:35-41.
294. van Os J., Kapur S. Schizophrenia. Lancet 2009, 374:635-645.
295. Vermot J., Niederreither K., Garnier J.M., Chambon P., Dolle P. Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1763-1768.
296. Vitelli F., Morishima M., Taddei I., Lindsay E.A., Baldini A. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum. Mol. Genet. 2002, 11:915-922.
297. Vitelli F., Taddei I., Morishima M., Meyers E.N., Lindsay E.A., Baldini A. A genetic link between Tbx1 and fibroblast growth factor signaling. Development 2002, 129:4605-4611.
298. Volk D.W., Matsubara T., Li S., Sengupta E.J., Georgiev D., Minabe Y., Sampson A., Hashimoto T., Lewis D.A. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am. J. Psychiatry 2012, 169:1082-1091.
299. Wallace M.L., Burette A.C., Weinberg R.J., Philpot B.D. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 2012, 74:793-800.
300. Wang Y., Medvid R., Melton C., Jaenisch R., Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 2007, 39:380-385.
301. Wang Y., Li G., Stanco A., Long J.E., Crawford D., Potter G.B., Pleasure S.J., Behrens T., Rubenstein J.L. CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 2011, 69:61-76.
302. Watanabe H., Nakamura M., Ohno T., Itahashi T., Tanaka E., Ohta H., Yamada T., Kanai C., Iwanami A., Kato N., Hashimoto R. Altered orbitofrontal sulcogyral patterns in adult males with high-functioning autism spectrum disorders. Soc. Cogn. Affect. Neurosci. 2014, 9:520-528.
303. Whitfield-Gabrieli S., Thermenos H.W., Milanovic S., Tsuang M.T., Faraone S.V., McCarley R.W., Shenton M.E., Green A.I., Nieto-Castanon A., LaViolette P., Wojcik J., Gabrieli J.D., Seidman L.J. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1279-1284.
304. Wu P., Teot L., Murdoch G.H., Monaghan-Nichols P., McFadden K. Neuropathology of 22q11 deletion syndrome in an infant. Pediatr. Dev. Pathol. 2014, 17:386-392.
305. Xu B., Hsu P.K., Stark K.L., Karayiorgou M., Gogos J.A. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion. Cell 2013, 152:262-275.
306. Yamagishi C., Hierck B.P., Gittenberger-De Groot A.C., Yamagishi H., Srivastava D. Functional attenuation of UFD1l, a 22q11.2 deletion syndrome candidate gene, leads to cardiac outflow septation defects in chicken embryos. Pediatr. Res. 2003, 53:546-553.
307. Yoshida K., Kuo F., George E.L., Sharpe A.H., Dutta A. Requirement of CDC45 for postimplantation mouse development. Mol. Cell. Biol. 2001, 21:4598-4603.
308. Zarchi O., Attias J., Raveh E., Basel-Vanagaite L., Saporta L., Gothelf D. A comparative study of hearing loss in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. J. Pediatr. 2011, 158:301-306.
309. Zhou Y., Wang J., Lu X., Song X., Ye Y., Zhou J., Ying B., Wang L. Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia. J. Mol. Neurosci. 2013, 49:594-599.
310. Zikopoulos B., Barbas H. Altered neural connectivity in excitatory and inhibitory cortical circuits in autism. Front. Hum. Neurosci. 2013, 7:609.